author-photo

Johnathan Joffe

Royal College of Physicians

2

Papers

31

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Capivasertib (AZD5363) plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER-positive breast cancer (FAKTION): A randomized, double-blind, placebo-controlled, phase II trial.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (30)
Addressing the burden of cancer in East Africa through cascaded training and education by local doctors.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)